Recent guidelines for the treatment of neuropathic pain have listed tricyclic antidepressants as first line drugs. Among tricyclic antidepressants, amitriptyline and nortriptyline are established drugs for the treatment of neuropathic pain. However, tricyclic antidepressants do not seem to be used properly by Japanese physicians who treat patients with neuropathic pain. In patients using trycyclic antidepressants, the dose should be increased in patients who experience no pain relief or side-effects.

